Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Phase I/II studies to investigate nab-docetaxel for prostate and breast cancers

March 26, 2007

Terameprocol found effective in patients with oral leukoplakia

March 26, 2007

HEP27: a novel target for selective VTAs

March 23, 2007

IL-10: A prognostic factor and a target for high-risk melanoma patients

March 23, 2007

Both PHA-665752 and NK4 inhibit proliferation and migration of CRC cells

March 23, 2007

Indian researchers present findings on gefitinib and imatinib

March 23, 2007

Combination studies with sorafenib to continue after positive findings

March 22, 2007

SPA filing for phase III study of Xyotax plus carboplatin in women with NSCLC

March 22, 2007

Pain Therapeutics cleared for Israeli phase I metastatic melanoma study

March 22, 2007

CUV-1647 to be studied for prevention of phototoxicity in PDT

March 22, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...